Skip to main content
Top
Published in: Cancer Causes & Control 2/2024

22-09-2023 | Colorectal Cancer | Original Paper

Prevalence and predictors of colorectal cancer screening in the United States: evidence from the HINTS database 2018 to 2020

Authors: Joseph Atarere, Christopher Haas, Ted Akhiwu, Thilini Delungahawatta, Ashik Pokharel, Comfort Adewunmi, Eugene Annor, Vwaire Orhurhu, Jasmine Barrow

Published in: Cancer Causes & Control | Issue 2/2024

Login to get access

Abstract

Background

The incidence of colorectal cancer (CRC) and CRC-related mortality among young adults (< 50 years) has been on the rise. The American Cancer Society (ACS) reduced the CRC screening age to 45 in 2018. Few studies have examined the barriers to CRC screening among young adults.

Methods

Analyses were conducted using data from 7,505 adults aged 45–75 years who completed the 2018 to 2020 Health Information National Trends Survey. We examined the sociodemographic characteristics associated with CRC screening overall and by age group using separate multivariable logistic regression models.

Results

76% of eligible adults had received screening for CRC. Increasing age, Black racial group [OR 1.45; 95% CI (1.07, 1.97)], having some college experience, a college degree or higher [OR 1.69; 95% CI (1.24, 2.29)], health insurance coverage [OR 4.48; 95% CI (2.96, 6.76)], primary care provider access [OR 2.48; 95% CI (1.91, 3.22)] and presence of a comorbid illness [OR 1.39; 95% CI (1.12, 1.73)] were independent predictors of CRC screening. Current smokers were less likely to undergo CRC screening [OR 0.59; 95% CI (0.40, 0.87)]. Among adults aged 50–64 years, being of Hispanic origin [OR 0.60; 95% CI (0.39, 0.92)] was associated with a lower likelihood of CRC screening.

Conclusion

CRC screening rates among adults 45–49 years are low but are increasing steadily. Odds of CRC screening among Blacks is high which is encouraging while the odds among current smokers is low and concerning given their increased risk of developing CRC.
Literature
3.
go back to reference Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, US Preventive Services Task Force (2021) Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 325(19):1965–1977CrossRefPubMed Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, US Preventive Services Task Force (2021) Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 325(19):1965–1977CrossRefPubMed
4.
go back to reference Chang SH, Patel N, Du M, Liang PS (2022) Trends in early-onset vs late-onset colorectal cancer incidence by race/ethnicity in the United States Cancer statistics database. Clin Gastroenterol Hepatol 20(6):e1365–e1377CrossRefPubMed Chang SH, Patel N, Du M, Liang PS (2022) Trends in early-onset vs late-onset colorectal cancer incidence by race/ethnicity in the United States Cancer statistics database. Clin Gastroenterol Hepatol 20(6):e1365–e1377CrossRefPubMed
5.
go back to reference Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S (2019) Early-onset colorectal cancer in young individuals. Mol Oncol 13(2):109–131CrossRefPubMed Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S (2019) Early-onset colorectal cancer in young individuals. Mol Oncol 13(2):109–131CrossRefPubMed
7.
go back to reference Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih Y-CT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA: Cancer J Clin 68(4):250–281. https://doi.org/10.3322/caac.21457CrossRefPubMed Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih Y-CT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA: Cancer J Clin 68(4):250–281. https://​doi.​org/​10.​3322/​caac.​21457CrossRefPubMed
8.
go back to reference Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC (2020) Vital signs: colorectal cancer screening test use—United States, 2018. Morb Mortal Wkly Rep 69(10):253CrossRef Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC (2020) Vital signs: colorectal cancer screening test use—United States, 2018. Morb Mortal Wkly Rep 69(10):253CrossRef
11.
go back to reference Rogers CR, Korous KM, Brooks E, De Vera MA, Tuuhetaufa F, Lucas T et al (2022) Early-onset colorectal cancer survival differences and potential geographic determinants among men and women in Utah. Am Soc Clin Oncol Educ Book 42:1–16PubMedPubMedCentral Rogers CR, Korous KM, Brooks E, De Vera MA, Tuuhetaufa F, Lucas T et al (2022) Early-onset colorectal cancer survival differences and potential geographic determinants among men and women in Utah. Am Soc Clin Oncol Educ Book 42:1–16PubMedPubMedCentral
13.
go back to reference Yach D (2004) The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun 9(5):481–482CrossRef Yach D (2004) The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun 9(5):481–482CrossRef
14.
go back to reference von Elm E, Altman DG, Egger M et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349CrossRef von Elm E, Altman DG, Egger M et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349CrossRef
15.
go back to reference Mojica CM, Lind B, Gu Y, Coronado GD, Davis MM (2021) Predictors of colorectal cancer screening modality among newly age-eligible medicaid enrollees. Am J Prev Med 60(1):72–79CrossRefPubMed Mojica CM, Lind B, Gu Y, Coronado GD, Davis MM (2021) Predictors of colorectal cancer screening modality among newly age-eligible medicaid enrollees. Am J Prev Med 60(1):72–79CrossRefPubMed
16.
go back to reference Giovannucci E (2001) An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomark Prev 10(7):725–731 Giovannucci E (2001) An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomark Prev 10(7):725–731
17.
go back to reference Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT et al (2021) Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets 22(9):998–1009CrossRefPubMed Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT et al (2021) Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets 22(9):998–1009CrossRefPubMed
18.
go back to reference Taber JM, Klein WM, Suls JM, Ferrer RA (2017) Lay awareness of the relationship between age and cancer risk. Ann Behav Med 51(2):214–225CrossRefPubMed Taber JM, Klein WM, Suls JM, Ferrer RA (2017) Lay awareness of the relationship between age and cancer risk. Ann Behav Med 51(2):214–225CrossRefPubMed
19.
go back to reference Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC, Centers for Disease Control and Prevention (CDC) (2011) Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ 60(Suppl):42–46 Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC, Centers for Disease Control and Prevention (CDC) (2011) Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ 60(Suppl):42–46
20.
go back to reference Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ (2002) The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc 50(10):1651–1658CrossRefPubMed Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ (2002) The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc 50(10):1651–1658CrossRefPubMed
21.
go back to reference Wools A, Dapper EA, Leeuw JD (2016) Colorectal cancer screening participation: a systematic review. Eur J Public Health 26(1):158–168CrossRefPubMed Wools A, Dapper EA, Leeuw JD (2016) Colorectal cancer screening participation: a systematic review. Eur J Public Health 26(1):158–168CrossRefPubMed
22.
go back to reference Subramanian S, Klosterman M, Amonkar MM, Hunt TL (2004) Adherence with colorectal cancer screening guidelines: a review. Prev Med 38(5):536–550CrossRefPubMed Subramanian S, Klosterman M, Amonkar MM, Hunt TL (2004) Adherence with colorectal cancer screening guidelines: a review. Prev Med 38(5):536–550CrossRefPubMed
23.
go back to reference Cole AM, Jackson JE, Doescher M (2012) Urban–rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the centers for disease control’s behavioral risk factor surveillance study. Cancer Med 1(3):350–356CrossRefPubMedPubMedCentral Cole AM, Jackson JE, Doescher M (2012) Urban–rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the centers for disease control’s behavioral risk factor surveillance study. Cancer Med 1(3):350–356CrossRefPubMedPubMedCentral
25.
go back to reference Von Wagner C, Semmler C, Good A, Wardle J (2009) Health literacy and self-efficacy for participating in colorectal cancer screening: the role of information processing. Patient Educ Couns 75(3):352–357CrossRef Von Wagner C, Semmler C, Good A, Wardle J (2009) Health literacy and self-efficacy for participating in colorectal cancer screening: the role of information processing. Patient Educ Couns 75(3):352–357CrossRef
26.
go back to reference Wee CC, McCarthy EP, Phillips RS (2005) Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41(1):23–29CrossRefPubMed Wee CC, McCarthy EP, Phillips RS (2005) Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41(1):23–29CrossRefPubMed
27.
go back to reference Carmichael H, Cowan M, McIntyre R, Velopulos C (2020) Disparities in colorectal cancer mortality for rural populations in the United States: does screening matter? Am J Surg 219(6):988–992CrossRefPubMed Carmichael H, Cowan M, McIntyre R, Velopulos C (2020) Disparities in colorectal cancer mortality for rural populations in the United States: does screening matter? Am J Surg 219(6):988–992CrossRefPubMed
28.
go back to reference Shete S, Deng Y, Shannon J, Faseru B, Middleton D, Iachan R et al (2021) Differences in breast and colorectal cancer screening adherence among women residing in urban and rural communities in the United States. JAMA Netw Open 4(10):e2128000–e2128000CrossRefPubMedPubMedCentral Shete S, Deng Y, Shannon J, Faseru B, Middleton D, Iachan R et al (2021) Differences in breast and colorectal cancer screening adherence among women residing in urban and rural communities in the United States. JAMA Netw Open 4(10):e2128000–e2128000CrossRefPubMedPubMedCentral
29.
go back to reference Hu J, Wu Y, Ji F, Fang X, Chen F (2020) Peer support as an ideal solution for racial/ethnic disparities in colorectal cancer screening: evidence from a systematic review and meta-analysis. Dis Colon Rectum 63(6):850–858CrossRefPubMed Hu J, Wu Y, Ji F, Fang X, Chen F (2020) Peer support as an ideal solution for racial/ethnic disparities in colorectal cancer screening: evidence from a systematic review and meta-analysis. Dis Colon Rectum 63(6):850–858CrossRefPubMed
30.
go back to reference Leone LA, Allicock M, Pignone MP, Walsh JF, Johnson L-S, Armstrong-Brown J, Carr CC, Langford A, Ni A, Resnicow K, Campbell MK (2016) Cluster randomized trial of a church-based peer counselor and tailored newsletter intervention to promote colorectal cancer screening and physical activity among older African Americans. Health Educ Behav 43(5):568–576. https://doi.org/10.1177/1090198115611877CrossRefPubMed Leone LA, Allicock M, Pignone MP, Walsh JF, Johnson L-S, Armstrong-Brown J, Carr CC, Langford A, Ni A, Resnicow K, Campbell MK (2016) Cluster randomized trial of a church-based peer counselor and tailored newsletter intervention to promote colorectal cancer screening and physical activity among older African Americans. Health Educ Behav 43(5):568–576. https://​doi.​org/​10.​1177/​1090198115611877​CrossRefPubMed
31.
go back to reference Lawrence D, Weigel L, Dale P, Smith B, Honaker MD (2017) Presenting stage in colon cancer is associated with insurance status. Am Surg 83(7):728–732CrossRefPubMed Lawrence D, Weigel L, Dale P, Smith B, Honaker MD (2017) Presenting stage in colon cancer is associated with insurance status. Am Surg 83(7):728–732CrossRefPubMed
32.
go back to reference Hoehn RS, Rieser CJ, Phelos H, Sabik LM, Nassour I, Paniccia A (2021) Association between Medicaid expansion and diagnosis and management of colon cancer. J Am Coll Surg 232(2):146–156CrossRefPubMed Hoehn RS, Rieser CJ, Phelos H, Sabik LM, Nassour I, Paniccia A (2021) Association between Medicaid expansion and diagnosis and management of colon cancer. J Am Coll Surg 232(2):146–156CrossRefPubMed
33.
go back to reference Brewer KC, Peacock NR, Ferrans CE, Campbell RT, Polite B, Carnahan L et al (2020) Gender-and race-based differences in barriers and facilitators to early detection of colon cancer. J Women’s Health 29(9):1192–1202CrossRef Brewer KC, Peacock NR, Ferrans CE, Campbell RT, Polite B, Carnahan L et al (2020) Gender-and race-based differences in barriers and facilitators to early detection of colon cancer. J Women’s Health 29(9):1192–1202CrossRef
34.
go back to reference Lukin DJ, Jandorf LH, Dhulkifl RJ, Thélémaque LD, Christie JA, Itzkowitz SH, DuHamel KN (2012) Effect of comorbid conditions on adherence to colorectal cancer screening. J Cancer Educ 27(2):269–276CrossRefPubMedPubMedCentral Lukin DJ, Jandorf LH, Dhulkifl RJ, Thélémaque LD, Christie JA, Itzkowitz SH, DuHamel KN (2012) Effect of comorbid conditions on adherence to colorectal cancer screening. J Cancer Educ 27(2):269–276CrossRefPubMedPubMedCentral
35.
go back to reference Guiriguet C, Pera G, Castells A, Toran P, Grau J, Rivero I et al (2017) Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study. BMC Cancer 17(1):1–10CrossRef Guiriguet C, Pera G, Castells A, Toran P, Grau J, Rivero I et al (2017) Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study. BMC Cancer 17(1):1–10CrossRef
36.
go back to reference Perea MD, Castano-Vinyals G, Altzibar JM, Ascunce N, Moreno V, Tardon A et al (2012) Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study. Gac Sanit 26(4):301–310PubMed Perea MD, Castano-Vinyals G, Altzibar JM, Ascunce N, Moreno V, Tardon A et al (2012) Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study. Gac Sanit 26(4):301–310PubMed
37.
go back to reference Carrasco-Garrido P, Hernandez-Barrera V, Lopez de Andres A, Jimenez-Trujillo I, Gallardo Pino C, Jimenez-Garcıa R (2014) Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain. Eur J Public Health 24(2):264–270CrossRefPubMed Carrasco-Garrido P, Hernandez-Barrera V, Lopez de Andres A, Jimenez-Trujillo I, Gallardo Pino C, Jimenez-Garcıa R (2014) Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain. Eur J Public Health 24(2):264–270CrossRefPubMed
38.
go back to reference Liu BY, O’Malley J, Mori M, Fagnan LJ, Lieberman D, Morris CD et al (2014) The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Family Med 27(5):669–681CrossRef Liu BY, O’Malley J, Mori M, Fagnan LJ, Lieberman D, Morris CD et al (2014) The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Family Med 27(5):669–681CrossRef
39.
go back to reference Castañeda SF, Gallo LC, Nodora J, Talavera GA, Penedo FJ, Evenson KR et al (2019) Colorectal cancer screening among hispanics/latinos in the HCHS/SOL sociocultural ancillary study. Prev Med Rep 15:100947CrossRefPubMedPubMedCentral Castañeda SF, Gallo LC, Nodora J, Talavera GA, Penedo FJ, Evenson KR et al (2019) Colorectal cancer screening among hispanics/latinos in the HCHS/SOL sociocultural ancillary study. Prev Med Rep 15:100947CrossRefPubMedPubMedCentral
40.
go back to reference Ansa BE, Coughlin SS, Alema-Mensah E, Smith SA (2018) Evaluation of colorectal cancer incidence trends in the United States (2000–2014). J Clin Med 7(2):22CrossRefPubMedPubMedCentral Ansa BE, Coughlin SS, Alema-Mensah E, Smith SA (2018) Evaluation of colorectal cancer incidence trends in the United States (2000–2014). J Clin Med 7(2):22CrossRefPubMedPubMedCentral
41.
go back to reference May FP, Glenn BA, Crespi CM, Ponce N, Spiegel BM, Bastani R (2017) Decreasing black-white disparities in colorectal cancer incidence and stage at presentation in the United States improving colorectal cancer disparities. Cancer Epidemiol Biomark Prev 26(5):762–768CrossRef May FP, Glenn BA, Crespi CM, Ponce N, Spiegel BM, Bastani R (2017) Decreasing black-white disparities in colorectal cancer incidence and stage at presentation in the United States improving colorectal cancer disparities. Cancer Epidemiol Biomark Prev 26(5):762–768CrossRef
42.
go back to reference Lee DC, Liang H, Chen N, Shi L, Liu Y (2020) Cancer screening among racial/ethnic groups in health centers. Int J Equity Health 19(1):1–7CrossRef Lee DC, Liang H, Chen N, Shi L, Liu Y (2020) Cancer screening among racial/ethnic groups in health centers. Int J Equity Health 19(1):1–7CrossRef
43.
go back to reference Agrawal S, Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C, Romero Y et al (2005) Colorectal cancer in African americans. Official J Am College Gastroenterol 100(3):515–523CrossRef Agrawal S, Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C, Romero Y et al (2005) Colorectal cancer in African americans. Official J Am College Gastroenterol 100(3):515–523CrossRef
46.
go back to reference Orhurhu V, Gao C, Agudile E, Monegro W, Urits I, Orhurhu MS, Olatoye D, Viswanath O, Hirji S, Jones M, Ngo A, Aiudi C, Simopoulos T, Gill J (2021) Socioeconomic disparities in the utilization of spinal cord stimulation therapy in patients with chronic pain. Pain Pract 21(1):75–82. https://doi.org/10.1111/papr.12936CrossRefPubMed Orhurhu V, Gao C, Agudile E, Monegro W, Urits I, Orhurhu MS, Olatoye D, Viswanath O, Hirji S, Jones M, Ngo A, Aiudi C, Simopoulos T, Gill J (2021) Socioeconomic disparities in the utilization of spinal cord stimulation therapy in patients with chronic pain. Pain Pract 21(1):75–82. https://​doi.​org/​10.​1111/​papr.​12936CrossRefPubMed
48.
go back to reference Robie L, Alexandru D, Bota DA (2011) The use of patient navigators to improve cancer care for hispanic patients. Clin Med Insights: Oncol 5:CMO-S6074 Robie L, Alexandru D, Bota DA (2011) The use of patient navigators to improve cancer care for hispanic patients. Clin Med Insights: Oncol 5:CMO-S6074
49.
go back to reference Viramontes O, Bastani R, Yang L, Glenn BA, Herrmann AK, May FP (2020) Colorectal cancer screening among hispanics in the United States: disparities, modalities, predictors, and regional variation. Prev Med 138:106146CrossRefPubMed Viramontes O, Bastani R, Yang L, Glenn BA, Herrmann AK, May FP (2020) Colorectal cancer screening among hispanics in the United States: disparities, modalities, predictors, and regional variation. Prev Med 138:106146CrossRefPubMed
50.
go back to reference Hama H, Tabuchi T, Ito Y, Fukushima W, Matsunaga I, Miyashiro I, Nakayama T (2016) Smoking behavior and participation in screening for lung, gastric, and colorectal cancers. Jpn J Public Health 63(3):126–134 Hama H, Tabuchi T, Ito Y, Fukushima W, Matsunaga I, Miyashiro I, Nakayama T (2016) Smoking behavior and participation in screening for lung, gastric, and colorectal cancers. Jpn J Public Health 63(3):126–134
51.
go back to reference Sanford NN, Sher DJ, Butler S, Xu X, Ahn C, D’Amico AV et al (2019) Cancer screening patterns among current, former, and never smokers in the United States, 2010–2015. JAMA Netw Open 2(5):e193759–e193759CrossRefPubMedPubMedCentral Sanford NN, Sher DJ, Butler S, Xu X, Ahn C, D’Amico AV et al (2019) Cancer screening patterns among current, former, and never smokers in the United States, 2010–2015. JAMA Netw Open 2(5):e193759–e193759CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence and predictors of colorectal cancer screening in the United States: evidence from the HINTS database 2018 to 2020
Authors
Joseph Atarere
Christopher Haas
Ted Akhiwu
Thilini Delungahawatta
Ashik Pokharel
Comfort Adewunmi
Eugene Annor
Vwaire Orhurhu
Jasmine Barrow
Publication date
22-09-2023
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2024
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01795-8

Other articles of this Issue 2/2024

Cancer Causes & Control 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine